BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

Pharmaceuticals

Sort by Latest
Dutch competition authority ACM imposes EUR 20 million fine on orphan drug manufacturer Leadiant for excessive pricing
The Netherlands Authority for the Consumer and Markets’ ("ACM") announced focus on drug price developments has finally come to a tangible enforcement result: a fine of almost EUR 20 million imposed on Leadiant, manufacturer of the orphan drug CDCA-Leadiant. This penalty decision follows the announcement by the ACM in 2018, repeated in2020 and 2021, that it would scrutinize over-pricing of medicines. The prices of medicines have long been part of a public debate. In its role of the...
July 21, 2021
6 min read
Worldwide Interpol operation Pangea XIV leads to shutdowns...
Operation Pangea is a yearly recurring operation in which Interpol...
June 24, 2021
2 min read
Spanish courts say “no” to the evergreening on data...
Three recent judgments handed down by the Central Administrative...
June 14, 2021
8 min read
First medicinal cannabis drug listed on the Australian...
On 1 May 2021 Epidyolex, the first medicinal cannabis drug product...
May 6, 2021
1 min read
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations
The Chinese Supreme Court (“SPC”) released on 29 October 2020 the “Provisions on Several...
November 13, 2020
6 min read
Australian Courts apply “European Support” test to find key Wyeth’s Prevnar 13 patent invalid
In the recent decision in the Australian front of the Prevnar 13 patent litigation, Merck...
November 4, 2020
10 min read
AstraZeneca held liable for additional healthcare costs
In a judgment of 14 October 2020 the District Court The Hague ruled in a landslide decision that AstraZeneca...
October 15, 2020
10 min read
Post-Transition Brexit: New MHRA Guidelines on Medicines
With a post-transition Brexit looming on the horizon, the Medicines and Healthcare products Regulatory...
September 30, 2020
7 min read
A vaccine for COVID 19 –risks and liabilities in international perspective
As the development of vaccines against COVID-19 is progressing, the question becomes urgent who will...
September 8, 2020
17 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.